InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,159.60
(
1.07%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.46
(
0.35%
)
Bitcoin
64,105.71
(
-0.59%
)
Post# of 27676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

sunspotter

Send PM Follow Ignore
Followers 216
Posts 15862
Boards Moderated 7
Alias Born 06/02/2007

sunspotter

Re: onthegreen post# 8242

Thursday, 10/08/2015 9:57:20 AM

Thursday, October 08, 2015 9:57:20 AM

Post# of 27676
"BEVERLY HILLS, Calif., Oct. 7, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc. (RCHA) ("Rich" or the "Company") announced ............... Through this new partnership, Theradex will lead the Company in finalizing the Investigational New Drug Application (IND #124642) with the U.S. FDA for Rich's lead drug RP-323 in patients with AML."

Yeah, they're running out of lies.

They already used that one last year, and it wasn't true then either:

"Rich Pharmaceuticals submitted an investigational new drug (IND) application in October 2014, to conduct a clinical trial for its lead compound RP-323 in Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) with the U.S. Food and Drug Administration (FDA)."

http://ih.advfn.com/p.php?pid=nmona&article=65739296

"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

"Nobody ever went broke underestimating the intelligence of the American public."

H. L. Mencken

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up